Medical Linear Accelerator Market Report 2025

This medical linear accelerator market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The medical linear accelerator market size has grown strongly in recent years. It will grow from $3.69 billion in 2024 to $4 billion in 2025 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to increasing prevalence of cancer, advances in radiation therapy technology, government support and funding for cancer treatment, increasing availability of public and private healthcare infrastructure, and rising awareness of radiation therapy as a cancer treatment.

The medical linear accelerator market size is expected to see strong growth in the next few years. It will grow to $5.54 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to expanding cancer treatment centers in emerging economies, increased focus on personalized cancer treatment, supportive government policies and cancer care initiatives, and a and a rising geriatric population. Major trends in the forecast period include technological advancements in medical linear accelerators, continuous advancements in LINAC technology, innovations such as intensity modulated radiation therapy (IMRT), the launch of newer medical linear accelerators, real-time organ motion management, and new dose delivery improvements.

The growing burden of cancer is expected to drive the expansion of the medical linear accelerator market in the future. The rising demand for cancer treatment is fueled by the increasing number of cancer cases worldwide, influenced by factors such as aging populations, lifestyle changes, and environmental factors. This situation necessitates more advanced and accessible healthcare solutions. Medical linear accelerators are crucial in cancer treatment as they deliver precise, high-energy radiation beams that target and destroy cancerous cells while minimizing damage to surrounding healthy tissue. This precision makes them essential for effective and controlled radiation therapy. For example, in January 2024, the American Cancer Society reported that approximately 297,790 new cases of invasive breast cancer were diagnosed in women in 2023. As a result, the growing cancer burden is driving the growth of the medical linear accelerator market.

Leading companies in the medical linear accelerator market are focusing on advancing treatment planning through the use of artificial intelligence (AI) and machine learning algorithms. Innovations such as AI-enhanced imaging are being developed to improve treatment precision and patient outcomes while optimizing operational efficiency. AI-enhanced imaging provides clearer and more accurate images, which aids in better tumor detection, localization, and personalized treatment planning. For instance, in May 2024, Elekta, a Sweden-based neuroscience company, introduced its latest linear accelerator, the Evo, a CT-Linac equipped with advanced AI-enhanced imaging. This new system supports both offline and online adaptive radiation therapy as well as improved image-guided radiation therapy treatments. The Evo allows clinicians to choose the best radiation therapy technique tailored to each patient's needs. Its adaptive radiotherapy capabilities are designed to reduce uncertainties and protect surrounding organs. The Evo system features advanced AI and anatomy-specific algorithms through Iris, which enhances high-definition imaging for precise target visualization and increased automation. Additionally, Elekta has expanded its software offerings with Elekta ONE Planning, powered by MIM, which includes distributed treatment planning, faster dose calculations, and AI-driven contouring and dose planning automation.

In August 2023, BEBIG Medical GmbH, a German company specializing in high-quality radiation therapy products for cancer treatment, formed a partnership with SHINVA to enhance their Radiation Therapy Business. This collaboration combines the expertise and strengths of both BEBIG Medical and SHINVA, enabling them to provide dependable hardware along with an intuitive operating system. The aim is to make LINAC technology more accessible globally and to promote affordable healthcare for a larger population. SHINVA is a medical equipment provider based in China.

Major companies operating in the medical linear accelerator market are Mitsubishi Heavy Industries Ltd., Toshiba Corporation, Siemens Healthineers, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Hitachi High-Tech Corporation, Elekta AB, Shinva Medical Instrument Co. Ltd., Accuray Incorporated, Brainlab AG, Mevion Medical Solutions, ViewRay Inc., PTW Freiburg GmbH, CIVCO Medical Solutions, C-RAD, Panacea Medical Technologies Pvt. Ltd., Zygo Corporation, ProTom International, Altair Technologies Inc., AccSys Technology Inc., Mirada Medical, Huiheng Medical Inc., BEVATECH GmbH.

North America was the largest region in the medical linear accelerator market in 2024. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the medical linear accelerator market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical linear accelerator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A medical linear accelerator (LINAC) is a device used in radiation therapy to deliver high-energy X-rays or electron beams for the treatment of cancerous tumors. It operates by accelerating electrons to high speeds with microwave technology and directing these electrons toward a target, which produces radiation precisely aimed at the tumor. This precision is crucial for targeting tumors effectively while minimizing damage to surrounding healthy tissues.

The main types of medical linear accelerators are low-energy and high-energy systems. Low-energy systems are used for treating superficial tumors and cancers near the surface of the body, producing lower-energy X-rays that are effective for targeting tumors in superficial tissues. Medical linear accelerators are categorized as dedicated linear accelerators and non-dedicated linear accelerators. They are used in various treatment types, including intensity-modulated radiation therapy, volumetric modulated arc therapy (VMAT), image-guided radiation therapy, stereotactic radiosurgery, and stereotactic body radiotherapy. The primary end users of these devices include hospitals, clinics, and research centers.

The medical linear accelerator market research report is one of a series of new reports that provides medical linear accelerator market statistics, including medical linear accelerator industry global market size, regional shares, competitors with an medical linear accelerator market share, detailed medical linear accelerator market segments, market trends and opportunities, and any further data you may need to thrive in the medical linear accelerator industry. This medical linear accelerator market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical linear accelerator market consists of sales of advanced LINAC system, compact and fast medical linear accelerator system, and robotic medical linear accelerator system. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.